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Small for gestational age infants and the association with placental and umbilical
cord morphometry: a digital imaging study
Abstract:
Introduction:
Individual placental and umbilical cord morphometry have been previously
identified to have an association with fetal growth. This study aims to identify
which of the morphometric measurements in combination are associated with
pregnancies with small for gestational age (SGA) infants using digital imaging of
the delivered placenta.
Material and methods:
This study examined 1005 placentas from consecutively delivered singleton
pregnancies in a tertiary center. Standardized images of each placenta were
taken. Placental weight and thickness; umbilical cord length and diameter were
measured on gross examination. Distance from placental cord insertion site to
placental margin, length and breadth of the placenta and placental chorionic
surface area were measured digitally using ImageJ software. Logistic regression
models and area under the curve (AUC) were used to identify the best subset of
morphometric measurements to classify infants as SGA (<10th centile). 
Results:
Overall, 141 (14%) infants were SGA. The morphometric measurements at
delivery most strongly associated with the classification of infants as SGA were
placental weight (AUC=0.806) and placental surface area (AUC=0.749).Of
the potential antenatal morphometric measurements, umbilical cord diameters,
both placental (AUC=0.644) and fetal end (AUC=0.629) were most strongly
associated with SGA. A logistic regression model with maternal age, smoking
status, current history of pre-eclampsia, umbilical cord length, placental weight,
birthweight to placental weight ratio and umbilical cord diameter (placental end)
had a sensitivity of 53% and a false positive rate of 2% (AUC=0.945) for the








Placental and umbilical cord morphometry measured at delivery are different
between SGA and non-SGA infants. Further studies are warranted to investigate
the feasibility and accuracy of ultrasound to measure placental and umbilical cord
morphometry during pregnancy.
Keywords: small for gestational age; placental measurements; umbilical cord
measurements; morphometry; digital imaging; birthweight
Introduction
Small for gestational age (SGA) is a term used to describe infants with birthweight of
less than the 10th percentile for their gestational age at delivery. 10% of all pregnancies
are affected by inadequate fetal growth [1]. SGA infants are at an increased risk
of perinatal morbidity and mortality compared to infants with birthweight that is
appropriate for gestational age [2]. SGA infants are also known to have an increased
risk of developing coronary heart disease, stroke, hypertension and type II diabetes
mellitus in later life [3, 4].
Research focuses on timely antenatal detection of SGA, to reduce associated
risks of perinatal morbidity and mortality. Compared to SGA fetuses identified
antenatally, SGA fetuses that have not been identified antenatally have four times the
odds of adverse fetal outcome (odds ratio, 4.1; 95% CI, 2.5-6.8) [5]. Whenever SGA is
diagnosed during the antenatal period, increased surveillance and timely delivery aims
to improve perinatal outcome, balancing the risk of antepartum stillbirth by remaining
in utero and iatrogenic prematurity potentially causing significant morbidity or neonatal
death by too early intervention [6]. The detection rate of SGA using fetal biometry
varies between reported studies [7, 8, 9], with improvement in the detection rate when
customized charts were used adjusting to maternal variables [10].
Multiple factors contribute to infants being SGA, including placental and
umbilical cord abnormalities. The placenta performs the diversity of functions of
all major organs while these develop and mature in the fetus [11]. It is accepted that
placental weight correlates with birthweight [12, 13]. Placental weight has been
found to be a justifiable proxy of fetal metabolic rate, and placental efficiency can
be calculated from placental weight and birthweight [14]. Non-central placental cord
insertions have also been associated with reduced transport efficiency [15] and adverse
pregnancy outcomes including SGA [16, 17]. Proctor et al developed a nomogram of
umbilical cord diameter for pathological examination of the placenta using a high-risk








The role of these morphometric measurements in combination has never been
examined. A combination of different placental and umbilical cord morphometry may
be a more sensitive tool to identify SGA. The objective of this study was therefore
to examine and identify different morphometry of the placenta and umbilical cord
at delivery using digital imaging and use these measurements to classify infants
as SGA. We aimed to identify which of the placental and umbilical cord variables
are individually most strongly associated with SGA. We then aimed to develop a
multivariable model to classify infants as SGA using a combination of the individual
morphometric measurements. This will inform future prospective studies where the
feasibility and accuracy of ultrasound to measure these during pregnancy can be
examined.
Materials and Methods
This study was conducted between 28th January 2016 and 27th April 2016 in a tertiary
university teaching hospital, with 4800 deliveries per annum. Consecutive singleton
pregnancies delivered at or after 24 weeks gestation during the study period were
eligible for recruitment. Women were identified from the delivery registers and those
who labored spontaneously were approached within 24 hours of delivery. Women who
were admitted for elective caesarean delivery or induction of labor were approached on
admission. Multiple pregnancies were excluded. 
Placentas from consecutively delivered singleton pregnancies between 24 and
42 weeks gestation were routinely examined by the midwife at delivery and placed
in separate labeled plastic containers after delivery. The containers were kept in the
placental refrigerator with the temperature maintained between 4 and 6oC. All study
placentas were identified and examined within 48 hours following delivery by two
researchers who were blinded to the pregnancy outcomes, under supervision from a
perinatal pathologist. Complete pathological examination of the placenta was only
performed for clinical indications, with no routine pathological examination performed
for all placentas. The placentas selected for complete laboratory analysis were examined
prior to formalin fixation. 
A unique study identification number was given to each placenta. The
membranes were then trimmed and the umbilical cord excised from the placenta,
about 1 cm from the insertion site. Morphometric measurements documented on gross
examination include trimmed placental weight (in grams), placental thickness at the
placental cord insertion site (in mm), umbilical cord length (in cm), umbilical cord
diameters at the placental and fetal ends (in mm), umbilical cord handedness (left or
right handedness) and number of coils. Coiling index was calculated by dividing the
number of coils by umbilical cord length. The placenta was then placed on the base of
the photo reproduction table with lamp ring (Figure 1). A standardised digital image
of the placental fetal surface without the umbilical cord and a separate image of the
umbilical cord were then taken using Nikon D3100 Digital Single-lens Reflex (DSLR)
camera, attached at a fixed distance from the base of the photo reproduction table.








Distance from PCI to placental margin (in mm), and length and breadth of
the placenta (in cm) were measured using ImageJ software version 1.50 (Figure 2),
available freely from http://rsb.info.nih.gov/ij. ImageJ is an open platform for scientific
image analysis that allows automatic analysis of images using macro programming.
Placental chorionic surface area (cm2) was calculated by first creating a black image
of the placenta in a white background, and then using the measure and ruler option in
Image J to calculate the surface area of the black image (Figure 3). 
Maternal characteristics obtained from the medical charts included maternal age,
height, booking weight, body mass index (BMI), parity, smoking status at booking and
medical history. Obesity was defined as BMI of equal or greater than 30 kg/m2. Birth
weight, gestation age and gender of the newborns were recorded. The placental weight/
birthweight (PW/BW) ratio was calculated. Birthweight of less than the 10th percentile
for gestational age was defined as small for gestational age (SGA). The birthweight
percentile was calculated using the customized chart for the population of Ireland [19].
Statistical analysis
Numeric variables were tested for normality and presented as mean (SD) for normally
distributed variables. Maternal demographics and placental and umbilical cord
morphometry were compared across groups (SGA, non-SGA) using independent
samples t test for comparing means and chi-squared tests for categorical variables. A
5% level of significance was used for all tests and no adjustment was made for multiple
testing. Pearson’s correlation coefficient (r) was used to measure the strength of the
association between placental and umbilical cord morphometry with absolute values
of r from 0.40-0.59 considered moderately strong, 0.60-0.79 considered strong and ≥
0.8 considered very strong [20]. Receiver Operating Characteristic (ROC) curves were
generated and the Area under the Curve (AUC) used to compare the ability of each
placental and umbilical cord morphometry to distinguish between SGA and non-SGA
infants. Multiple logistic regression analysis was then used to classify infants as SGA
using all placental and umbilical cord morphometry, adjusting for known confounders
(maternal age, parity, BMI, smoking status and medical history). Variable selection was
used to identify the best subset of morphometric measurements to maximize AUC. All
statistical analyses were carried out using the software package IBM SPSS for Windows
version 22. 
Ethical approval
Approval for the study was obtained from the institutional review board, the Health
Service Executive Research Ethics Committee (REC Ref 32/13). An information leaflet
was given to all participants. Written informed consent was obtained during recruitment










A total of 1140 infants between 24+0 and 42+0 weeks gestation were delivered between
28th January 2016 and 27th April 2016. After excluding multiple pregnancies (n=19
sets), 1102 singleton pregnancies were deemed suitable for the study. 35 (3.3%) women
declined to participate, 25 placentas (2.3%) were not labeled and 29 (2.6%) of placentas
were not available for analysis. Eight women (0.8%) did not have complete data and
were excluded from the analysis, leaving 1005 (91.2%) of women and placentas in the
dataset for analysis. 31 (3%) placentas had complete pathological examination. 
Maternal demographics are summarized in Table 1. The mean maternal age
was 32 years (SD 5.5), with 36.0% of the women aged 35 and over. The majority
of the women were of white ethnicity (92.9%) and 36.9% women were nulliparous.
The demographic profile of the study cohort is consistent with the overall obstetric
population in Ireland[21]. 14% of babies were characterized as SGA (141/1005) while
86% (863/1005) were non-SGA. Six (4%) placentas from the 141 SGA infants had
complete pathological examination. 
Table 2 describes the demographics of women in the SGA and non-SGA groups.
There were significantly more nulliparous women in the SGA group compared to
the non-SGA group (45.4% vs. 35.5%, P=0.035). There were also significantly more
smokers (29.1% vs. 13.4%, P<0.0001), more women with essential hypertension (5.7%
vs. 1.3%, P<0.0001), and women with pre-eclampsia (4.3% vs. 1.5%, P=0.027).
Table 3 compares placental and umbilical cord morphometry for the SGA and
non-SGA infants. There were statistically significant (P<0.05) differences in placental
morphometric measurements including placental weight, thickness at placental cord
insertion, distance of placental cord insertion to placental margin, placental surface
area and BW/PW ratio for SGA placentas compared to non-SGA placentas (Table 3).
Similarly, there were statistically significant differences (P<0.05) in umbilical cord
morphometric measurements including umbilical cord length, umbilical cord diameters
(placental and fetal ends) and coiling index in SGA umbilical cords compared to
non-SGA umbilical cords (Table 3). The morphometric measurements most strongly
associated with SGA were placental weight (AUC=0.806) and placental surface area
(AUC=0.749) (Figure 4). Placental weight and surface area were moderately strongly
correlated (r=0.59, P<0001). Of the potential antenatal morphometric measurements,
umbilical cord diameters, both placental (AUC=0.644) and fetal end (AUC=0.629)
were most strongly associated with SGA. Both cord diameters were strongly correlated
(r=0.66, P<0.001).
The best fitting logistic regression model included maternal age, smoking status,
current history of pre-eclampsia, umbilical cord length, placental weight, birthweight
to placental weight ratio and umbilical cord diameter (placental end) (Table 4) with a
sensitivity of 53% and a false positive rate of 2% (AUC=0.945) for the classification of









Our findings demonstrate differences between placental and umbilical cord
morphometry of non-SGA and SGA infants at delivery. Of these measurements,
placental weight and surface area were most strongly associated with SGA. Distance
from placental cord insertion to placental margin, placental thickness, diameter of
umbilical cord (both placental and fetal ends) and coiling index can potentially be
measured using obstetric ultrasound. Of these, diameters of umbilical cords were
identified in this study as most strongly associated with SGA though not as strong as
placental weight and surface area. Combining maternal characteristics, placental and
umbilical cord morphometry was shown to improve the sensitivity of the model for the
classification of infants as SGA.
The dimensions of the delivered placenta measured after delivery reveals its
cumulative development from conception to delivery [13]. The growth of the placenta is
directly related to its functional efficiency as the sole fetal source of both nutrients and
oxygen [13]. Advancement in obstetric ultrasonography allows accurate identification
and measurements of placental biometry and has increased the obstetricians’ interest in
ultrasonographic placental examination. Jauniaux et al in 1994 reported an association
between abnormal placental development detected on ultrasound and subsequent
abnormal fetal growth [22]. Since then, the use of 2-dimensional sonographic placental
morphometric measurements, including placental diameter and thickness was found to
have predictive ability for fetal growth [23]. 3-dimensional ultrasonography has also
been shown to allow accurate placental morphometric measurements and these may be
used as early predictors of fetal growth [24]. 
Currently, no direct measures of placental and umbilical cord biometry are
used in clinical practice for screening of SGA. Our study provides an important initial
step to identify both placental and umbilical cord morphometry that are potentially
associated with SGA and to assess their use individually and in combination to correctly
classify infants as SGA. The results can be used to inform future prospective antenatal
studies where the feasibility and accuracy of measuring the placental and umbilical cord
morphometry on ultrasound can be examined.
Research on antenatal detection of SGA is usually focused on ultrasonographic
fetal measurements and Doppler studies. A prospective cohort study by Sovio et al
investigating the diagnostic effectiveness of ultrasonic fetal biometry in the third
trimester as a screening test for SGA reported a sensitivity of 57% for universal
ultrasonography using fetal biometry and estimated fetal weight in the third trimester
with a false positive rate of 10% [9]. Miranda et al reported a sensitivity of 52% for
detecting SGA using estimated fetal weight (EFW) between 32 to 36 weeks gestation
with a false positive rate of 10% [25]. By using a screening model combining maternal
characteristics, EFW, uterine artery Doppler, Placental Growth Factor (PlGF) and
conjugated estriol, their sensitivity increased to 61% though the inclusion of the
biochemical markers increases the cost of screening [25]. The results of the above
studies may possibly be improved by adding ultrasound measurements of both the
placenta and umbilical cord as part of the screening tool. Our findings suggest that
the placental and umbilical cord morphometry may contribute as a component to a








The present study has several limitations. We were unable to differentiate
between infants with fetal growth restriction or constitutionally small infants in the
SGA cohort. Routine pathological examination was not performed for all placentas in
this study, thus limiting our assessment of other pathology associated with SGA such
as vilitis and thrombotic disease. There may be other factors contributing to SGA not
accounted for in our analysis. Further, generalization of our results to other populations
may be limited due to the relative homogenous white European population in our
cohort. 
A major strength of this study is the recruitment of participants from consecutive
singleton deliveries thus minimizing selection/ascertainment bias. To minimize the
observer and reporting bias, the researchers were blinded to the outcomes including
gestational age and birthweight. The large number of placentas for examination allows
precise comparison between the SGA and non-SGA groups. 
Our results identified differences in placental and umbilical cord morphometry
at delivery between non-SGA and SGA infants. Combining fetal biometry with
placental and umbilical cord morphometry on ultrasound may potentially improve the
SGA detection rate. Morphometry identifiable antenatally on ultrasound may be useful
as predictors for SGA but prospective cohort studies are warranted to investigate its
feasibility and accuracy. 
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Characteristics n (%) Mean (SD)
Age (years) 32 (5.5)
Yes 643 (64.0%)under35
No 362 (36.0%)
White Irish 813 (81.3%)
Eastern European 82 (8.2%)





BMI at first visit (kg/m2) 25.7 (5.3)






























aMissing data for some variables, % of valid responses given
BMI: body mass index; CD: cesarean delivery; ART: assisted reproductive
technology








Non-SGA (n=863) SGA (n=141) P-value
Maternal age
≥35 years









Smoker 110 (13.4%) 39 (29.1%) <0.0001
Essential hypertension 11 (1.3%) 8 (5.7%) <0.0001





















































Distance of PCI to
placental margin3
5.21 (2.16) 4.69 (2.31) 0.009 0.563
Birthweight/Placental
weight (BW/PW) ratio












10.72 (2.11) 9.83 (2.47) <0.0001 0.644
Diameter – fetal end
(mm)3










1 Data reported as mean (SD)
2 P-value from independent samples t test








SGA: small for gestational age; PCI: placental cord insertion; AUC: Area under the
curve
Table 4: Multivariable logistic regression of predictor variables for SGA infants
(n=1005)
Predictor variables OR (95% CI) P-value



















Placental weight 0.96 (0.96-0.97) <0.001

















Figure 1: Photo reproduction table with lamp ring
Figure 2: Digital measurements of fetal surface of placenta
The digital images of the placentas were analyzed digitally using ImageJ software
version 1.50, freely downloaded from http://rsb.info.nih.gov/ij
Figure 3: Black and white image of placenta for surface area calculation
The digital images of the placentas were analyzed digitally using ImageJ software
version 1.50, freely downloaded from http://rsb.info.nih.gov/ij
Figure 4: Receiver–operating characteristics curves for prediction of small-for-
gestational-age infants by placental weight and placental chorionic surface area
Figure 5: Receiver-operating characteristics curve combining maternal smoking status,
present pre-eclampsia, umbilical cord length, birthweight/placental weight ratio,
placental weight and umbilical cord diameter (placental end)
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